A detailed history of Blue Edge Capital, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Blue Edge Capital, LLC holds 16,372 shares of JNJ stock, worth $2.7 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares
16,372
Previous 16,348 0.15%
Holding current value
$2.7 Million
Previous $2.59 Million 7.5%
% of portfolio
0.41%
Previous 0.45%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$144.38 - $157.78 $3,465 - $3,786
24 Added 0.15%
16,372 $2.39 Million
Q1 2024

May 15, 2024

SELL
$155.22 - $162.74 $1.68 Million - $1.76 Million
-10,840 Reduced 39.87%
16,348 $2.59 Million
Q4 2023

Feb 15, 2024

BUY
$145.6 - $158.88 $49,940 - $54,495
343 Added 1.28%
27,188 $4.26 Million
Q3 2023

Nov 14, 2023

BUY
$155.75 - $174.48 $4,828 - $5,408
31 Added 0.12%
26,845 $4.18 Million
Q2 2023

Aug 21, 2023

BUY
$154.35 - $166.11 $7,717 - $8,305
50 Added 0.19%
26,814 $4.44 Million
Q1 2023

May 15, 2023

BUY
$151.05 - $180.26 $56,945 - $67,958
377 Added 1.43%
26,764 $4.15 Million
Q4 2022

Feb 13, 2023

BUY
$160.2 - $179.79 $3,364 - $3,775
21 Added 0.08%
26,387 $4.66 Million
Q3 2022

Nov 15, 2022

BUY
$161.33 - $179.52 $23,554 - $26,209
146 Added 0.56%
26,366 $4.31 Million
Q2 2022

Aug 10, 2022

SELL
$168.19 - $186.01 $37,338 - $41,294
-222 Reduced 0.84%
26,220 $4.65 Million
Q1 2022

May 16, 2022

BUY
$158.14 - $179.59 $26,093 - $29,632
165 Added 0.63%
26,442 $4.69 Million
Q2 2021

Aug 13, 2021

SELL
$159.48 - $171.07 $4,784 - $5,132
-30 Reduced 0.11%
26,277 $4.33 Billion
Q1 2021

May 12, 2021

BUY
$153.07 - $170.48 $30,920 - $34,436
202 Added 0.77%
26,307 $4.32 Billion
Q4 2020

Feb 09, 2021

BUY
$137.11 - $157.38 $7,952 - $9,128
58 Added 0.22%
26,105 $4.11 Million
Q3 2020

Nov 04, 2020

SELL
$140.38 - $153.83 $123,815 - $135,678
-882 Reduced 3.28%
26,047 $3.88 Billion
Q2 2020

Aug 10, 2020

BUY
$128.81 - $155.51 $1.37 Million - $1.65 Million
10,598 Added 64.89%
26,929 $3.79 Million
Q1 2020

May 12, 2020

BUY
$111.14 - $153.99 $592,709 - $821,228
5,333 Added 48.49%
16,331 $2.14 Million
Q1 2019

May 14, 2019

BUY
$125.72 - $139.79 $251 - $279
2 Added 0.02%
10,998 $0
Q4 2018

Feb 14, 2019

BUY
$122.84 - $147.84 $368 - $443
3 Added 0.03%
10,996 $1.42 Million
Q3 2018

Nov 15, 2018

BUY
$121.58 - $142.88 $364 - $428
3 Added 0.03%
10,993 $0
Q2 2018

Aug 14, 2018

BUY
$119.4 - $131.76 $358 - $395
3 Added 0.03%
10,990 $0
Q1 2018

May 14, 2018

BUY
$125.1 - $148.14 $250 - $296
2 Added 0.02%
10,987 $0
Q4 2017

Feb 15, 2018

BUY
$131.22 - $143.62 $328,443 - $359,480
2,503 Added 29.51%
10,985 $0
Q3 2017

Nov 15, 2017

BUY
$129.47 - $135.38 $258 - $270
2 Added 0.02%
8,482 $1.1 Billion
Q2 2017

Aug 14, 2017

BUY
N/A
8,480
8,480 $0

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $431B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Blue Edge Capital, LLC Portfolio

Follow Blue Edge Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blue Edge Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Blue Edge Capital, LLC with notifications on news.